CAS 119141-88-7

(-)-Omeprazolo

Descrizione:

(-)-Omeprazolo è un inibitore della pompa protonica (PPI) utilizzato principalmente per trattare condizioni come la malattia da reflusso gastroesofageo (GERD) e le ulcere peptiche riducendo la produzione di acido gastrico. È caratterizzato dalla sua natura chirale, esistendo come un singolo enantiomero, il che contribuisce alla sua attività farmacologica. Il composto ha una formula molecolare che include elementi come carbonio, idrogeno, azoto e ossigeno, riflettendo la sua struttura complessa che presenta un anello di benzimidazolo e un gruppo piridina. (-)-Omeprazolo viene tipicamente somministrato nella sua forma rivestita entericamente per garantire stabilità e assorbimento nel tratto gastrointestinale. Il suo meccanismo d'azione implica l'inibizione irreversibile dell'enzima H+/K+ ATPasi nelle cellule parietali gastriche, portando a una diminuzione della secrezione acida. La sostanza è generalmente ben tollerata, sebbene possa avere effetti collaterali, inclusi disturbi gastrointestinali e potenziali interazioni con altri farmaci. A causa della sua azione specifica ed efficacia, (-)-Omeprazolo rimane un farmaco ampiamente prescritto nella gestione dei disturbi correlati all'acido.

Formula: C₁₇H₁₉N₃O₃S

InChI: InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1

InChI key: InChIKey=SUBDBMMJDZJVOS-DEOSSOPVSA-N

SMILES: S(CC1=C(C)C(OC)=C(C)C=N1)(=O)C=2NC=3C(N2)=CC=C(OC)C3

Sinonimi:

• (-)-Omeprazole
• (5-methoxy-1H-benzimidazol-2-yl)[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfoniumolate
• (S)-(-)-Omeprazole
• (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
• (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
• (S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
• (S)-Esomeprazole
• 1H-Benzimidazole, 5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-
• 1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, (S)-
• 1H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-
• 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-1H-benzimidazole
• 6-Methoxy-2-[(R)-(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzoimidazole
• 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
• 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
• 6-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
• 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
• Esofag
• Esomeprazole(Mg)
• Esomeprazole(Na、Mg)
• Inexium

Esomeprazole

CAS: 119141-88-7

Formula: C₁₇H₁₉N₃O₃S

Purezza: 99%

Colore e forma: Solid

Peso molecolare: 345.4161

Ref: IN-DA0077XZ

Esomeprazole-d3

CAS: 119141-88-7

Formula: C₁₇H₁₆D₃N₃O₃S

Colore e forma: Pale Yellow Solid

Peso molecolare: 348.44

Ref: 4Z-O-0216

Esomeprazole

CAS: 119141-88-7

Esomeprazole

Purezza: ≥98%

Peso molecolare: 345.42g/mol

Ref: 54-BUP17319

Esomeprazole

CAS: 119141-88-7

Esomeprazole

Purezza: 99%

Peso molecolare: 345.42g/mol

Ref: 54-OR1028226

(S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole

CAS: 119141-88-7

Purezza: 95.0%

Colore e forma: Solid

Peso molecolare: 345.4200134277344

Ref: 10-F219545

Esomeprazole

CAS: 119141-88-7

Esomeprazole is the S-isomer of omeprazole, inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis.

Formula: C₁₇H₁₉N₃O₃S

Purezza: 97.3%

Colore e forma: Solid

Peso molecolare: 345.42

Ref: TM-T20626

Esomeprazole-d3 Sodium

Prodotto controllato

CAS: 119141-88-7

Formula: C₁₇H₁₅D₃N₃NaO₃S

Colore e forma: Neat

Peso molecolare: 370.42

Ref: TR-E668302

Esomeprazole

CAS: 119141-88-7

Esomeprazole is a drug used for treating gastroesophageal reflux disease (GERD). It belongs to the class of proton pump inhibitors (PPIs) and inhibits gastric acid secretion by binding to the H+/K+-ATPase enzyme in the stomach. It has been shown to inhibit various drug interactions, including those with inhibitor drugs, nonsteroidal anti-inflammatory drugs, control analysis, enzyme activities, blood sampling, and more. Esomeprazole also has inhibitory properties that may be due to its ability to reduce gastric acidity and its esomeprazole content. Esomeprazole is used as a treatment for GERD and other conditions such as Zollinger-Ellison syndrome. Omeprazole is another PPI that is sometimes used instead of esomeprazole.

Formula: C₁₇H₁₉N₃O₃S

Purezza: Min. 95%

Peso molecolare: 345.42 g/mol

Ref: 3D-FE61562